Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Robert Freedman to Evoked Potentials, Auditory

This is a "connection" page, showing publications Robert Freedman has written about Evoked Potentials, Auditory.

 
Connection Strength
 
 
 
3.868
 
  1. Hunter SK, Hoffman MC, D'Alessandro A, Freedman R. Developmental Windows for Effects of Choline and Folate on Excitatory and Inhibitory Neurotransmission During Human Gestation. Dev Psychobiol. 2024 Feb; 66(2).
    View in: PubMed
    Score: 0.808
  2. Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT, Waldo MC, Hall MH, Bowles A, Woodward L, Ross RG, Freedman R. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry. 2004 Oct; 161(10):1822-8.
    View in: PubMed
    Score: 0.212
  3. Kisley MA, Olincy A, Robbins E, Polk SD, Adler LE, Waldo MC, Freedman R. Sensory gating impairment associated with schizophrenia persists into REM sleep. Psychophysiology. 2003 Jan; 40(1):29-38.
    View in: PubMed
    Score: 0.188
  4. Simosky JK, Stevens KE, Adler LE, Freedman R. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl). 2003 Feb; 165(4):386-96.
    View in: PubMed
    Score: 0.187
  5. Olincy A, Ross RG, Harris JG, Young DA, McAndrews MA, Cawthra E, McRae KA, Sullivan B, Adler LE, Freedman R. The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia. Biol Psychiatry. 2000 Jun 01; 47(11):969-77.
    View in: PubMed
    Score: 0.157
  6. Freedman R, Olsen-Dufour AM, Olincy A. P50 inhibitory sensory gating in schizophrenia: analysis of recent studies. Schizophr Res. 2020 04; 218:93-98.
    View in: PubMed
    Score: 0.154
  7. Waldo MC, Freedman R. Neurobiological abnormalities in the relatives of schizophrenics. J Psychiatr Res. 1999 Nov-Dec; 33(6):491-5.
    View in: PubMed
    Score: 0.151
  8. Freedman R, Adler LE, Nagamoto HT, Waldo MC. Selection of digital filtering parameters and P50 amplitude. Biol Psychiatry. 1998 Jun 15; 43(12):921-2.
    View in: PubMed
    Score: 0.137
  9. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 1998; 24(2):189-202.
    View in: PubMed
    Score: 0.133
  10. Young DA, Waldo M, Rutledge JH, Freedman R. Heritability of inhibitory gating of the P50 auditory-evoked potential in monozygotic and dizygotic twins. Neuropsychobiology. 1996; 33(3):113-7.
    View in: PubMed
    Score: 0.116
  11. Waldo M, Myles-Worsley M, Madison A, Byerley W, Freedman R. Sensory gating deficits in parents of schizophrenics. Am J Med Genet. 1995 Dec 18; 60(6):506-11.
    View in: PubMed
    Score: 0.115
  12. Miller CL, Freedman R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience. 1995 Nov; 69(2):371-81.
    View in: PubMed
    Score: 0.114
  13. Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry. 2015 Jan; 172(1):17-31.
    View in: PubMed
    Score: 0.107
  14. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993 Dec; 150(12):1856-61.
    View in: PubMed
    Score: 0.100
  15. Griffith JM, Waldo M, Adler LE, Freedman R. Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep. Psychiatry Res. 1993 Oct; 49(1):29-39.
    View in: PubMed
    Score: 0.099
  16. Cullum CM, Harris JG, Waldo MC, Smernoff E, Madison A, Nagamoto HT, Griffith J, Adler LE, Freedman R. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res. 1993 Aug; 10(2):131-41.
    View in: PubMed
    Score: 0.098
  17. Hunter SK, Kisley MA, McCarthy L, Freedman R, Ross RG. Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use. Schizophr Bull. 2011 Nov; 37(6):1200-8.
    View in: PubMed
    Score: 0.078
  18. Baker NJ, Staunton M, Adler LE, Gerhardt GA, Drebing C, Waldo M, Nagamoto H, Freedman R. Sensory gating deficits in psychiatric inpatients: relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatry. 1990 Mar 01; 27(5):519-28.
    View in: PubMed
    Score: 0.077
  19. Simosky JK, Freedman R, Stevens KE. Olanzapine improves deficient sensory inhibition in DBA/2 mice. Brain Res. 2008 Oct 03; 1233:129-36.
    View in: PubMed
    Score: 0.069
  20. Freedman R, Nagamoto H. Brain evoked potentials as predictors of risk. Recent Dev Alcohol. 1988; 6:323-31.
    View in: PubMed
    Score: 0.067
  21. Martin LF, Hall MH, Ross RG, Zerbe G, Freedman R, Olincy A. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry. 2007 Dec; 164(12):1900-6.
    View in: PubMed
    Score: 0.066
  22. Davalos DB, Kisley MA, Freedman R. Behavioral and electrophysiological indices of temporal processing dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 2005; 17(4):517-25.
    View in: PubMed
    Score: 0.054
  23. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl). 2004 Jun; 174(1):54-64.
    View in: PubMed
    Score: 0.051
  24. Leonard S, Gault J, Hopkins J, Logel J, Vianzon R, Short M, Drebing C, Berger R, Venn D, Sirota P, Zerbe G, Olincy A, Ross RG, Adler LE, Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002 Dec; 59(12):1085-96.
    View in: PubMed
    Score: 0.047
  25. Freedman R, Adler LE, Olincy A, Waldo MC, Ross RG, Stevens KE, Leonard S. Input dysfunction, schizotypy, and genetic models of schizophrenia. Schizophr Res. 2002 Mar 01; 54(1-2):25-32.
    View in: PubMed
    Score: 0.044
  26. Simosky JK, Stevens KE, Kem WR, Freedman R. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol Psychiatry. 2001 Oct 01; 50(7):493-500.
    View in: PubMed
    Score: 0.043
  27. Kisley MA, Olincy A, Freedman R. The effect of state on sensory gating: comparison of waking, REM and non-REM sleep. Clin Neurophysiol. 2001 Jul; 112(7):1154-65.
    View in: PubMed
    Score: 0.042
  28. Adler LE, Olincy A, Cawthra E, Hoffer M, Nagamoto HT, Amass L, Freedman R. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology. 2001 Jun; 24(6):671-9.
    View in: PubMed
    Score: 0.042
  29. Adams CE, Stevens KE, Kem WR, Freedman R. Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus. Brain Res. 2000 Sep 22; 877(2):235-44.
    View in: PubMed
    Score: 0.040
  30. Stevens KE, Kem WR, Freedman R. Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice. Biol Psychiatry. 1999 Nov 15; 46(10):1443-50.
    View in: PubMed
    Score: 0.038
  31. Adler LE, Freedman R, Ross RG, Olincy A, Waldo MC. Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol Psychiatry. 1999 Jul 01; 46(1):8-18.
    View in: PubMed
    Score: 0.037
  32. Ross RG, Olincy A, Harris JG, Radant A, Hawkins M, Adler LE, Freedman R. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am J Med Genet. 1999 Apr 16; 88(2):188-99.
    View in: PubMed
    Score: 0.036
  33. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks MJ, Rose GM. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology. 1996 Aug; 15(2):152-62.
    View in: PubMed
    Score: 0.030
  34. Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R. Nicotinic receptor function in schizophrenia. Schizophr Bull. 1996; 22(3):431-45.
    View in: PubMed
    Score: 0.029
  35. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 1992 Jul 31; 587(1):130-6.
    View in: PubMed
    Score: 0.023
  36. Hunter SK, Mendoza JH, D'Anna K, Zerbe GO, McCarthy L, Hoffman C, Freedman R, Ross RG. Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating. Am J Psychiatry. 2012 Jun; 169(6):616-24.
    View in: PubMed
    Score: 0.023
  37. Adler LE, Gerhardt GA, Franks R, Baker N, Nagamoto H, Drebing C, Freedman R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 1990 Mar; 31(3):297-309.
    View in: PubMed
    Score: 0.019
  38. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, Freedman R, Adams CE. Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry. 2010 May; 51(5):535-49.
    View in: PubMed
    Score: 0.019
  39. Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM, Drebing C, Nagamoto H, Bickford-Wimer P, Franks R. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 1987; 13(4):669-78.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)